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The Mouse Formin mDia1 Is a Potent
Actin Nucleation Factor Regulated by Autoinhibition
When tested for their effects on actin polymerization
kinetics of 4 M actin monomers by pyrene-actin nucle-
ation assay (5% pyrene label), both mDia1 constructs
Fang Li and Henry N. Higgs*
Department of Biochemistry
Dartmouth Medical School
Hanover, New Hampshire 03755 potently accelerate polymerization at nanomolar con-
centration (Figure 1C). Polymerization acceleration indi-
cates increased filament formation [12]. Using slopes at
polymerization midpoints, we calculated filament con-Summary
centration (see Supplemental Data) by assuming a
barbed-end elongation rate of 11.6 M1s1 [13]. ForFormin proteins are widely expressed in eukaryotes
mDia1-748, filament concentration increases linearly toand play essential roles in assembling specific cellular
at least 25 nM, above which the polymerization midpointactin-based structures [1, 2]. Formins are defined by
is reached too rapidly for slope determination (Figurea Formin Homology 2 (FH2) domain, as well as a pro-
1D). In contrast, filament concentration increase be-line-rich FH1 domain that binds the actin monomer
comes nonlinear for mDia1-549 above 10 nM. In thebinding protein, profilin, and other ligands [3]. Con-
linear range, the ratio of filaments:mDia1 is 1:5 for bothstructs including FH2 of budding yeast Bni1 or fission
constructs. Use of 100% pyrene-labeled actin monomeryeast Cdc12 formins nucleate actin filaments in vitro
causes a 30%–50% decrease in filament concentration[4–7]. In this study, we demonstrate that FH2-con-
for both constructs (Figure 1D), suggesting that mDia1taining constructs of murine mDia1 (also called p140
has slightly reduced affinity for pyrene-labeled actin.mDia or Drf1) are much more potent actin nucleators
mDia1-748-mediated actin filament generation variesthan the yeast formins. FH1 is necessary for nucleation
sigmoidally with actin monomer concentration (Figurewhen actin monomers are profilin bound. mDia1 is
2A), resulting in Hill coefficients of 3.12 and 2.71 for 5%a member of the Diaphanous formin subfamily (Dia),
and 100% pyrene-actin, respectively. Filament produc-whose members contain an N-terminal Rho GTPase
tion occurs rapidly even at low monomer concentrationsbinding domain (GBD) and a C-terminal Diaphanous
at which spontaneous actin polymerization is negligibleautoinhibitory domain (DAD, [8]). Based on cellular and
(Supplementary Figure 1), although a slight lag occursin vitro binding studies, an autoinhibitory model for
under these conditions. The fact that filaments are pro-Dia formin regulation proposes that GBD binding to
duced below the pointed-end critical concentration ofDAD inhibits Dia-induced actin remodeling, whereas
0.5–0.7 M (Figure 2A inset) suggests that nucleatedRho binding activates by releasing GBD from DAD
filaments can elongate in the barbed-end direction. Fila-[9, 10]. Supporting this model, our results show that
ment production from monomers does not occur at oran N-terminal mDia1 construct strongly inhibits actin
below the barbed-end critical concentration of 0.1 Mnucleation by the C terminus. RhoA partially relieves
(Figure 2A inset). These results suggest that mDia1 is ainhibition but does so when bound to either GDP or
potent nucleation factor capable of producing filamentsGTP analogs. Both N- and C-terminal mDia1 con-
that elongate toward their barbed ends.structs appear to be multimeric.
Profilin, an actin monomer binding protein, inhibits
spontaneous nucleation and prevents monomer addi-
Results and Discussion tion to filament pointed ends but not barbed ends [12].
In mammalian cells, a large proportion of monomeric
Effect of C-Terminal mDia1 Constructs actin is bound to profilin, leaving less than 1 M mono-
on Actin Polymerization mer unbound [12]. Thus, cellular nucleation factors must
We expressed two C-terminal constructs of mDia1 as operate on a monomer substrate that is primarily bound
glutathione S transferase (GST) fusion proteins in bacte- to profilin. Profilin also binds poly-proline sequences in
ria; these were mDia1-549, including FH1, FH2, and the FH1 domain of mDia1 and other formins [3] and acts
C-terminal domains, and mDia1-748, including FH2 and in concert with formins in cytokinetic actin ring assembly
the C terminus (Figure 1A). In the FH1 domain of mDia1- [14–16].
549, we find an in-frame deletion (amino acids 661–731) We tested profilin’s effect on nucleation by mDia1-
that does not correspond to intron/exon boundaries, 549, whose FH1 domain could bind up to five profilins,
which we suspect to be an artifact of RT-PCR cloning and by mDia1-748, which should not bind profilin. Addi-
(see Supplemental Data available with this article on- tion of a profilin concentration that reduces free actin
line). Because the deleted sequence contains 55% pro- monomer levels to about 0.2 M virtually eliminates
line, 18% glycine, one aromatic residue, and no charged mDia1-748-mediated nucleation but only reduces
residues, the region is probably largely unstructured and mDia1-549 nucleation by 20% (Figure 2B). Profilin inhibi-
serves as a binding site for profilin and SH3 binding tion of mDia1-748 correlates with its reduction of free-
proteins. Even with this deletion, the FH1 domain con- actin monomer levels (Figure 2C). These results suggest
tains five stretches of five or more prolines, which could that mDia1 can use profilin bound actin monomers to
bind profilin [11]. nucleate actin but that it requires its profilin binding FH1
domain to do so. mDia1 bound profilin may provide a
correctly positioned monomer for efficient nucleation.*Correspondence: henry.n.higgs@dartmouth.edu
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Figure 1. Polymerization Acceleration by mDia1
(A) Diagram of mDia1 protein. Abbreviations are as follows: GBD, GTPase binding domain; FH1, Formin Homology 1 domain; FH2, Formin
Homology 2 domain; DAD, Diaphanous Autoregulatory Domain. Lines above proteins represent constructs used in this study. mDia1-549
contains an internal deletion of amino acids 661–731 (dashed line below bar).
(B) Coomassie-stained SDS-PAGE of 1 mg bacterially expressed proteins used in this study. Lane 1 shows mDia1-549, 2 shows mDia1-748,
3 shows mDia1-N, and 4 shows RhoA.
(C) Pyrene-actin nucleation assays containing 4 M monomeric actin (5% pyrene-labeled) and the indicated nM concentrations of mDia1-
549 (red) or mDia1-748 (blue) in polymerization buffer (10 mM imidazole [pH 7.0], 50 mM KCl, 1 mM MgCl2, 1 mM EGTA, 0.1 mM ATP, and
0.5 mM DTT).
(D) Plot of nM filaments generated at 50% polymerization in the presence of mDia1-549 (red) or mDia1-748 (blue) with 4 M actin that is 5%
(triangles) or 100% pyrene-labeled (circles).
The minor inhibition of mDia1-549 by profilin may reflect mDia1 Weakly Caps Filament Barbed Ends
A construct containing the FH2 domain of the fissionprofilin’s inhibition of pointed-end elongation as well as
competition between mDia1 bound and mDia1 unbound yeast formin, Cdc12, tightly caps barbed ends [7],
whereas budding yeast Bni1 causes partial barbed-endprofilin for actin monomers.
Figure 2. Effect of Actin and Profilin Concentration on Polymerization Acceleration by mDia1
(A) Effect of actin monomer concentration. The indicated concentration of 5% (red) or 100% (black) pyrene-labeled actin was incubated with
2.5 nM mDia1-549, and the polymerization curve was recorded by fluorimetry. Filament concentrations were calculated from slopes at 50%
polymerization. The inset shows similar calculations from low concentrations of 100% pyrene-labeled actin with 25 nM mDia1-549.
(B) Effect of profilin. Actin monomers (4 M, 5% pyrene) were incubated in the absence or presence of both 8 M profilin and either 2.5 nM
mDia1-549 or mDia1-748.
(C) Curves of profilin effect on filament production by 2.5 nM mDia1-549 (red) mDia1-748 (blue) on 4 M actin (5% pyrene). Free actin values
on abscissa reflect the concentration not bound to profilin and are calculated under the assumption of a profilin:actin monomer dissociation
constant of 0.25 M.
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Figure 3. Effects of mDia1-549 on Filament Barbed Ends
(A) Effect of mDia1-549 on critical concentration. Actin monomers (6 M, 20% pyrene) were polymerized for 2 hr at 23C and then diluted in
the same buffer to the indicated concentrations alone (open black circles) or with 100 nM mDia1-549 (closed red circles). After 16 hr at 23C,
pyrene fluorescence intensity was recorded.
(B) Effect of mDia1-549 on the actin filament depolymerization rate. Actin monomers (5 M, 25% pyrene) were polymerized for 2 hr, then
diluted to 0.1 M in polymerization buffer alone (closed black circles) or in the presence of either 325 nM mDia1-549 (open red circles) or 50
nM cytochalasin D (closed green triangles).
(C) Plot of slope from 0–50 s against mDia1-549 (closed red circles) or cytochalasin D concentration (open green circles), from experiments
conducted as in panel B.
capping [4, 6]. Because both mDia1-549 and mDia1- merization acceleration by mDia1-549 (Figure 4A) or
mDia1-748 (not shown). Interestingly, although the IC50748 nucleate actin filaments at monomer concentrations
below the pointed-end critical concentration, neither for mDia1-N under these conditions is 2 nM, mDia1-
N is unable to completely inhibit actin polymerizationconstruct appears to cap barbed ends tightly. Direct
measurement of critical concentration in the presence of acceleration by mDia1-549. Based on filaments gener-
ated at 50% polymerization, inhibition plateaus atmDia1-549 confirms a lack of tight barbed-end capping.
These assays measure steady-state concentration of 90% at concentrations up to 1.4 M mDia1-N (Fig-
ure 4B).actin filaments after dilution in the absence or presence
of 100 nM mDia1-549. No effect is observed whether To verify that mDia1-N binds to the C-terminal mDia1
constructs, we conducted size exclusion chromatogra-mDia1-549 is added to prepolymerized filaments (Figure
3A) or is included during actin polymerization (not phy experiments. Interestingly, both mDia1-N and
mDia1-748 elute considerably earlier than predicted forshown). Inclusion of 5 mM NaPO4 does not change these
results (not shown), suggesting that capping does not spherical particles of their calculated masses (62 and
58 kDa, respectively) (Figure 4C), suggesting that bothdepend on retention of the phosphate product on actin
filaments after subunits hydrolyze ATP [12, 17]. Actin proteins are either multimeric or highly elongated.
mDia1-N elutes as a relatively symmetrical peak with afilament pelleting assays confirm that, in the absence
of pyrene label, mDia1-549 does not change the concen- calculated mass of 313 kDa, whereas mDia1-748 elutes
as a broad peak with a considerable tail and a calculatedtration of actin monomer (Figure S2 in the Supplemental
Data). mass of 271 kDa at the peak. The tail of mDia1-748
suggests dissociation of a multimeric complex duringWe tested whether mDia1 might partially cap filament
barbed ends, as has been observed for Bni1. These chromatography. When equal concentrations of
mDia1-N and mDia1-748 are mixed, they comigrate asassays measure filament depolymerization rates upon
dilution. Because depolymerization from barbed ends a single peak at a calculated MW of 510 kDa, close to
that expected of a 1:1 complex. Thus, mDia1-N andis more than 20-fold faster than from pointed ends [13],
barbed-end capping reduces the depolymerization rate. MDia1-748 bind tightly. mDia1-748 tailing is reduced in
this complex, suggesting that its multimeric state ismDia1-549 reduces the depolymerization rate, sug-
gesting barbed-end capping (Figure 3B). However, the more stable when in complex with mDia1.
mDia1-549 binds preformed actin filaments (Figuremaximal inhibition induced is 50% (Figure 3C). In con-
trast, cytochalasin D, which caps barbed ends at low 4D), with an apparent Kd of 3 M. This binding was
unaffected by prior filament binding to phalloidin (notconcentrations [18], causes a 10-fold decrease in the
depolymerization rate. Maximal inhibition is achieved at shown). Inclusion of mDia1-N blocks this interaction
(Figure 4D). Thus, mDia1-N blocks both nucleation andlow mDia1-549 concentrations (Figure 3C), suggesting
a high-affinity partial cap rather than a low-affinity cap. filament binding by mDia1-549.
As reported by others [9, 19], mDia1-N binds GST-
RhoA and prefers RhoA bound to the nonhydrolyzablemDia1 Is Autoinhibited
GTP analog, GMP-PNP, over RhoA bound to GDP (Fig-We expressed the N-terminal region of mDia1 (mDia1-N,
ure 4E). However, GDP-RhoA does bind mDia1-N. WhenFigure 1) and examined its effects on actin polymeriza-
tested in actin polymerization assays, RhoA partiallytion. Although it does not affect the polymerization kinet-
ics of actin alone, mDia1-N potently inhibits actin poly- relieves the inhibitory effect of mDia1-N on mDia1-549
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Figure 4. Autoinhibition of mDia1 and Partial Activation by RhoA
(A) Polymerization assays containing 4 mM actin monomer (5% pyrene) and indicated nM concentrations of additives.
(B) Inhibition curve of mDia1-N on polymerization acceleration by mDia1-549 under the conditions in (A). The striped bar indicates filaments
created by actin alone.
(C) Superdex 200 gel filtration chromatography of 2 M mDia1-N, mDia1-748, or the two components mixed. Eluate was monitored at 220
nm. Below the graph are Coomassie-stained SDS-PAGE results of eluate fractions, and these are aligned with the graph at approximate
elution positions.
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(Figure 4F). The fact that the RhoA effect saturates (Fig- in a multimer contributes one or more monomers to a
nucleus. An alternative hypothesis is that the partialure 4G) suggests that RhoA alone can not fully relieve
mDia1-N inhibition. At saturating concentrations, RhoA barbed-end capping by mDia1 slows elongation, which
would cause an underestimation in the number of fila-causes a 10%–12% recovery of MDia1-549 activity. Sur-
prisingly, this effect of RhoA occurs regardless of ments assembled by mDia1 and thus an increase in the
apparent mDia1:filament ratio.whether GMP-PNP or GDP is bound. Use of GTPS
instead of GMP-PNP does not alter this result (not The N terminus of mDia1 strongly inhibits nucleation
by the C terminus, supporting an autoinhibition modelshown). Analysis of nucleotide bound to RhoA reveals
that our nucleotide charging protocol results in full GMP- of regulation. This effect must be verified with full-length
mDia1. Another issue to be resolved with full-lengthPNP or GDP loading (Figure S3). GMP-PNP Cdc42 is
ineffective at relieving mDia1-549 inhibition by mDia1-N. protein is the possibility that inhibition occurs in trans
between subunits of a multimeric mDia1 complex. RhoA
only partially relieves autoinhibition, suggesting thatConclusions
The following evidence suggests that mDia1 is a potent other activating molecules might be required for full
relief of autoinhibition. The situation might be analogousnucleator that causes filament elongation in the barbed-
end direction: (1) mDia1 increases filament concentra- to that for WASp and N-WASP, for which combinations
of Cdc42, polyphosphoinositides, SH3 domain-con-tion when incubated with actin monomers; (2) this fila-
ment increase occurs within seconds even in the pres- taining proteins, and non-receptor tyrosine kinases can
relieve autoinhibition cooperatively [20].ence of low monomer concentrations that do not
spontaneously nucleate appreciably on this timescale; The lack of nucleotide specificity for RhoA-mediated
activation is puzzling but is not inconsistent with resultsand (3) mDia1-induced polymerization acceleration oc-
curs below the pointed-end critical concentration. from others; GDP-RhoA was found to inhibit interaction
between N- and C-terminal fragments of mDia1 by GST-The ability to form barbed-end nuclei in the absence
of profilin distinguishes mDia1 from fission yeast Cdc12, pulldown [9]. In these studies, the absence of apparent
GDP-RhoA binding to the mDia1 N terminus might havewhich tightly caps barbed ends but allows nucleation
and barbed-end elongation when bound to profilin [7]. been due to the low concentrations used (0.2 M RhoA
and 0.05 M mDia1 N terminus) because our studiesmDia1 appears more similar to Bni1, which allows
barbed-end elongation in the absence of profilin [4–6]. use concentrations that are more than 10-fold higher
and still do not reach 100% binding, implying that affinityHowever, mDia1 is at least 7-fold more potent than Bni1
at creating filaments. This difference may reflect a higher is weak. More quantitative binding studies are needed
to clarify this issue. Specificity for GTP-RhoA in cellsaffinity of mDia1 for actin monomers or nucleation mech-
anism that is different from that of dimer stabilization might be affected by Rho guanine nucleotide dissocia-
tion inhibitor (GDI, [21]), which could prevent GDP-RhoAproposed for Bni1. Because mDia1’s ability to partially
cap barbed ends might affect polymerization rates, we from interacting with mDia1. Other factors, such as pos-
sible RhoA dimerization at high concentration [22] orare not able to draw conclusions on nucleus size from
the present data. prenylation and associated modifications, may play
roles.An mDia1 construct containing the FH1 domain can
overcome profilin’s inhibition of nucleation, suggesting By our count, there are at least nine distinct mamma-
lian formin genes, some possessing several splice vari-that profilin-actin binding to FH1 provides a monomer
able to interact with the nascent nucleus. mDia1 inter- ants. Our work raises many additional questions, includ-
ing the following: What is the detailed mechanism ofacts with filament barbed ends, slowing but not stopping
monomer release from this end. These results suggest mDia1-mediated nucleation, and do other formins utilize
the same mechanism? Are other formins regulated bythat, as proposed for Bni1 as well as Cdc12 bound to
profilin, mDia1 might nucleate and allow barbed-end autoinhibition? What factors in addition to RhoA are
required for full relief of autoinhibition?elongation but remain bound at the barbed end.
Gel filtration chromatography suggests that nucle-
ation-competent mDia1 constructs are dynamic multi- Supplemental Data
Figure S1 displays the early timepoints of pyrene-actin polymeriza-mers, and the 5:1 ratio of mDia1:filaments produced
tion in the presence of two concentrations of mDia1-748. Althoughduring nucleation suggests that the functional mDia1
a slight polymerization lag exists, it is much shorter than those foundnucleation unit may be multimeric. More detailed multi-
under comparable conditions with yeast formins. Figure S2 controlsmerization studies, employing techniques that are not
for the possibility that pyrene-actin inhibits barbed-end capping by
affected by molecular shape, are required to determine mDia1 by showing that mDia1 does not change the critical concen-
the multimerization parameters of these proteins. How- tration of actin that is not labeled with pyrene. Figure S3 displays
evidence that RhoA is completely charged with GMP-PNP or withever, one possible scenario is that each mDia1 subunit
(D) Effect of mDia1-N on filament binding by mDia1-549. The indicated concentrations of prepolymerized actin filaments were mixed with 0.2
M mDia1-549 with or without 1 M mDia1-N. Filaments were pelleted by ultracentrifugation, and supernatants and pellets were analyzed.
(E) mDia1-N binding to GST-RhoA. GST-RhoA, bound to glutathione-sepharose, was loaded with GDP (D) or GMP-PNP (T), and the indicated
concentrations (in M) were incubated with 0.5 M mDia1-N. After centrifugation, mDia1-N in pellet (RhoA bound) and supernatant were
analyzed via Coomassie-stained SDS-PAGE.
(F) Effect of RhoA on the polymerization of 1 M actin monomer (5% pyrene) in the presence of 2.5 nM mDia1-549 and 2.5 nM mDia1-N.
(G) Concentration curves of RhoA or Cdc42 on filament production under the same conditions as those in (F).
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